SCHEMBL8239061

SCHEMBL8239061

BN1CCN(C(=O)c2cc(C)n(-c3ccccc3)c2-c2ccccc2)C(COc2ccc(C(=O)OC)cc2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.44
LMNA P02545 2/20 0.44
ALDH1A1 P00352 4/20 0.39
HTT P42858 2/20 0.39
MAPT P10636 2/20 0.39
MITF O75030 1/20 0.39
HPGD P15428 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
KDM4E B2RXH2 1/20 0.39
PKM P14618 1/20 0.39
MAPK1 P28482 4/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TSHR P16473 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3496017 0.90 TP53 (0.44) TP53LMNAALDH1A1HTTMAPT
SCHEMBL3494783 0.87 LMNA (0.41) TP53LMNAALDH1A1HTTMAPT
SCHEMBL4982433 0.83 CPT2 (0.37) TP53LMNAALDH1A1HTTMAPT
SCHEMBL3494574 0.81 PARP10 (0.37) TP53LMNAHTTMAPTSMN1; SMN2
SCHEMBL3494786 0.81 TP53 (0.43) TP53LMNAALDH1A1HTTMAPT
SCHEMBL3493772 0.81 USP30 (0.38) TP53LMNAHTTKDM4EPKM
SCHEMBL3493553 0.80 KAT7 (0.38)
SCHEMBL13340346 0.79 CHEK2 (0.41)
SCHEMBL8230196 0.79 CNR2 (0.38) TP53LMNAALDH1A1HTTMAPT
SCHEMBL4985477 0.78 CNR1 (0.35) TP53LMNAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007094513-A2 CYCLIC AMINE COMPOUND AND USE THEREOF FOR THE PROPHYLAXIS OR TREATMENT OF HYPERTENSION TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-08-23 WO disclosed